Status:
UNKNOWN
Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly
Lead Sponsor:
TC Erciyes University
Conditions:
Acromegaly
Eligibility:
All Genders
18+ years
Brief Summary
Acromegaly is a rare disease caused by growth hormone (GH) secreting pituitary adenoma in more than 95% of cases. Acromegaly can be seen sporadically or may be associated with a variety of genetic syn...
Detailed Description
Screening for AIP gene mutation is recommended in patients with pituitary adenomas of childhood-onset, GH or PRL secreting tumors who are diagnosed before the age of 30 years and positive family histo...
Eligibility Criteria
Inclusion
- \* Patients with acromegaly
Exclusion
- \* Patients with acromegaly due to ectopic GH or GHRH secreting tumors
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01902420
Start Date
November 1 2012
End Date
August 1 2014
Last Update
July 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erciyes University Medical School Department of Endocrinology
Kayseri, Turkey (Türkiye), 38030